Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Turner

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Biomolecules|August 26, 2023
Divergent Survival Outcomes Associated with Elevated Branched-Chain Amino Acid Levels among Older Adults with or without Hypertension and Diabetes: A Validated, Prospective, Longitudinal Follow-Up StudyErik Fung, Kwan Hung Ng, Timothy Kwok, et al.
Aging Cell|November 20, 2022
Cysteine restriction-specific effects of sulfur amino acid restriction on lipid metabolismSailendra N Nichenametla, Dwight A L Mattocks, Diana Cooke, et al.
The Lancet. Infectious Diseases|April 15, 2023
Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trialDaniel Jenkin, Daniel Wright, Pedro M Folegatti, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Biomolecules|August 26, 2023
Divergent Survival Outcomes Associated with Elevated Branched-Chain Amino Acid Levels among Older Adults with or without Hypertension and Diabetes: A Validated, Prospective, Longitudinal Follow-Up StudyErik Fung, Kwan Hung Ng, Timothy Kwok, et al.
Aging Cell|November 20, 2022
Cysteine restriction-specific effects of sulfur amino acid restriction on lipid metabolismSailendra N Nichenametla, Dwight A L Mattocks, Diana Cooke, et al.
The Lancet. Infectious Diseases|April 15, 2023
Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trialDaniel Jenkin, Daniel Wright, Pedro M Folegatti, et al.
Pageof 3